Breast cancer and hormonal supplements in postmenopausal women
- 16 September 1995
- Vol. 311 (7007) , 699-700
- https://doi.org/10.1136/bmj.311.7007.699
Abstract
Hormone supplements are clearly effective in relieving menopausal symptoms and preventing osteoporosis if taken for long enough. Do these and the putative protective effect on coronary heart disease1 make them the most important advance in preventive medicine in the past 50 years?2 Endometrial cancer is a serious problem with unopposed oestrogen, and, assuming that the protection from heart disease is real, breast cancer might still be a serious problem with either oestrogen or combined (opposed) preparations. How might these considerations balance out for a woman wanting to understand the benefits and risks? For a 50 year old woman the baseline lifetime risk of coronary heart disease is around 45%, of hip fracture is 15%, and of breast cancer is 8%. Clearly, such aggregate data will weigh differentially with the potential relief of symptoms, prevention …Keywords
This publication has 10 references indexed in Scilit:
- The alpha-tocopherol, beta-carotene lung cancer prevention study: Design, methods, participant characteristics, and compliancePublished by Elsevier ,2010
- The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 1995
- Measuring the impact of menopausal symptoms on quality of life.BMJ, 1993
- Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme InhibitorsNew England Journal of Medicine, 1993
- Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studiesAmerican Journal of Obstetrics and Gynecology, 1993
- Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer RiskEpidemiologic Reviews, 1993
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Complications of hormone replacement therapy in post-menopausal women.1992
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.1983